0000908662-16-000576.txt : 20160715 0000908662-16-000576.hdr.sgml : 20160715 20160715120906 ACCESSION NUMBER: 0000908662-16-000576 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160715 DATE AS OF CHANGE: 20160715 EFFECTIVENESS DATE: 20160715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neurovance, Inc. CENTRAL INDEX KEY: 0001544176 IRS NUMBER: 454090332 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-258396 FILM NUMBER: 161769146 BUSINESS ADDRESS: STREET 1: 43 THORNDIKE STREET STREET 2: SUITE S1-3 CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-758-0300 MAIL ADDRESS: STREET 1: 43 THORNDIKE STREET STREET 2: SUITE S1-3 CITY: CAMBRIDGE STATE: MA ZIP: 02141 D/A 1 primary_doc.xml X0707 D/A LIVE 0001544176 Neurovance, Inc. 43 THORNDIKE STREET SUITE S1-3 CAMBRIDGE MA MASSACHUSETTS 02141 617-758-0300 DELAWARE None None Corporation true 2011 Anthony A. McKinney 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Director President and CEO Gregg Beloff 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Acting Chief Financial Officer Campbell Murray Novartis Venture Fund Five Cambridge Center, Suite 603 Cambridge MA MASSACHUSETTS 02142 Director Daniel Omstead Tekla Healthcare/Tekla Life Sciences Inv 2 Liberty Square, 9th Floor Boston MA MASSACHUSETTS 02109 Director Brigitte Smith GBS Venture Partners Limited Level 5, 71 Collins Street Melbourne VIC C3 AUSTRALIA 3000 Director Paul Weiss Venture Investors Early Stage Fund IV 505 South Rosa Road, Suite 201 Madison WI WISCONSIN 53719 Director Timothy J. Barberich 48 Elm Street Concord MA MASSACHUSETTS 01742 Director William T. Pappafotopoulos 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Vice President, Finance and Administration Ross A. Reife 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Executive Officer Interim Chief Medical Officer Albert L. Sokol 111 Huntington Avenue Boston MA MASSACHUSETTS 02199 Executive Officer Secretary Jeffrey Bailey 43 Thorndike Street Suite S1-3 Cambridge MA MASSACHUSETTS 02141 Director Biotechnology No Revenues 06b true 0000908662-16-000489 2016-02-24 false true true false 0 6000000 6000000 0 Offering of Convertible Promissory Notes, including underlying shares to be issued upon certain conversions of the Notes. false 7 0 0 0 true false Neurovance, Inc. /s/ Albert L. Sokol Albert L. Sokol Secretary 2016-07-12